SUMMARY The hypothesis that colchicine and vinblastine, which are commonly used for therapeutic purposes and known to cause diarrhoea, decrease intestinal water transport by inhibition of Na-KATPase activity was tested in rats. Net fluid transport by jejunal segments was measured four hours after intraperitoneal injection of either 0-15 M NaCl (0 5 ml/100 g), colchicine (0 5 mg/100 g b.w.), or vinblastine (1 0 mg/100 g b.w.). Colchicine and vinblastine decreased net fluid transport: 3 0 + 0 9 (SE) and 4-6 ± 0 4 (SE) respectively, as compared to that transported by segments from rats injected with 0-15 M NaCl, 8-6 ± 0 7 (SE) g fluid/hour/g. Methylprednisolone (3-0 mg/100 g b.w.) abolished the inhibitory effect of cholchicine and vinblastine on fluid transport. Colchicine and vinblastine were found to decrease significantly mucosal Na-K-ATPase activity, 18-2 + 4-9 (SE); 25 2 + 2-4 (SE) respectively, as compared to that measured in rats injected with saline 40 6 ± 3-4 (SE) ,umol/ mg protein/hour. Pretreatment with methylprednisolone prevented the decrease in enzyme activity observed in rats injected with colchicine and vinblastine. The degree of inhibition in intestinal Na-K-ATPase activity was similar to that observed in fluid transport following colchicine and vinblastine. It is thus suggested that colchicine-induced inhibition of water transport is caused by inhibition of Na-K-ATPase activity, an effect which can be prevented by pretreatment with methylprednisolone.
elucidated. Colchicine was found to depress intestinal disaccharidase activities in man (Herbst et al., 1970) and guinea-pig (Cohen and McNamara, 1970) and to inhibit intestinal mucosal dehydrogenase in mice (Myren et al., 1966) . Colchicine and vinblastine have been reported to decrease also lipoprotein lipase activity by 50% in rats (Chajek et al., 1975) .
We tested the hypothesis that colchicine and vinblastine, two microtubular disrupting agents (Olmstead and Borisy, 1973) , inhibit water transport from the rat small intestine by inhibiting Na-KATPase activity, an enzyme which plays an important role in the intestinal absorption of sodium and water under basal conditions (Charney and Donowitz, 1977) . ' Address for correspondence: Dr D. Rachmilewitz, Division of Gastroenterology, Hadassah University Hospital, P.O. Box 499, Jerusalem, Israel. Received for publication 2 March 1978 Methods ANIMALS Non-fasted male rats (200-400 g) of Hebrew University strain were studied under the following experimental conditions: one group of rats was injected intraperitoneally with 0-15 M NaCl (0 5 ml/ 100 g body weight). A second group of rats was injected intraperitoneally with either colchicine, 0 5 mg/100 g body wt (Sigma Chemical Co., St. Louis, Mo.), or vinblastine, 1 mg/100 g body wt (Eli Lilly Co., Indianapolis, Ind.) dissolved freshly in 0-15 M NaCl. In a third group of rats a single subcutaneous injection of methyl prednisolone, 3 0 mg/100 g body weight (Upjohn, Belgium) was given 30 minutes before the intraperitoneal injection of either 0-15 M EXPERIMENTAL PROCEDURE Infusion studies Rats were anaesthetised with ether and a jejunal segment (10-15 cm long) 3 cm distal to the ligament of Treitz was separated. The segment was cannulated at both ends and flushed with 30 0 ml of a buffer solution containing 115 mM NaCl, 6 mM KCI, 10 mM NaHCO3, I 0 mM CaCl2, and 28 mM glucose. While the mesentery was still intact, the segment was connected to a reservoir and infused through the lumen of the intestinal segment with 50 ml of the above-mentioned buffer by means of a gas (95% 02-5 % C02) lift. The buffer recirculated at a rate of about 25 ml/min. The mesentery was cut, the serosal surface of the segment was washed with buffer, and the segment was then placed in a mineral oil bath. The temperature of the bath and reservoir were kept at 37°C and the hydrostatic pressure in the segment was 18 mm Hg (gas phase 95% 02 + 5% C02). The transported fluid from the infused segment appeared as droplets of 'sweat' on the serosal surface, accumulated at the bottom of the mineral oil bath and collected through a stopcock. The transported fluid from the first 30 minutes of the infusion was discarded, whereas that from the second 30 minutes' interval was weighed and analysed for sodium and potassium concentration (flame photometer 343, Instrumentation Laboratory Inc. (Quigley and Gotterer, 1969; Charney et al., 1974) . Protein concentration was determined (Lowry et al., 1951) .
The resuspended pellets were assayed for Na-KATPase activity (Quigley and Gotterer, 1969; Charney et al., 1974; . Triplicate samples of the 10 000 g pellets were incubated in a medium containing 100 mM NaCl, 20 mM KCI, 10 mM imidazole, 5-4 mM MgCl2, and 5-4 mM ATP (disodium salt, Sigma Chemical Co., Grade II) and in a medium from which the KCl was omitted and the NaCl concentration was 120 mM. The final incubation volume of 5 ml contained 100-400 ,ug protein. The incubation was carried out at 37°C for 15 minutes and terminated by the addition of 1 ml TCA 35%. Blanks containing no enzyme were run with each incubation. The samples were centrifuged and the inorganic phosphate liberated was measured (Fiske and SubbaRow, 1925) . Na-K-ATPase activity was defined as the difference between inorganic phosphate released in the presence and absence of potassium in the incubation mixture. Mg-ATPase was defined as the amount of inorganic phosphate released in the absence of potassium from the incubation mixture. The results are expressed as ,umoles inorganic phosphate liberated per mg protein per hour. Statistical evaluation of the data is based on Student's t test for unpaired data.
HISTOLOGICAL TECHNIQUES
Four hours after the intraperitoneal injection of 0-15 M NaCl, colchicine, or vinblastine, a 1-cm long section was removed from the jejunum and placed on a stiff piece of paper. The section was opened with scissors and was placed in Bouin's fixative. The fixed specimen was trimmed, dehydrated in ethanol, embedded in paraffin, serially sectioned at 4-5 microns and stained with haematoxylin and eosin.
Results
Colchicine and vinblastine decreased the amount of fluid transported by jejunal segments as compared to that transported by segments of rats injected with 0-15 M NaCl 3-0 ± 0-9 (SE), 46 ± 04 (SE), and 8-6 ± 0 7 (SE) g fluid/hour/g respectively (Table 1) .
Concomitant with the decrease in the fluid transport, colchicine and vinblastine treatment resulted in a decrease in sodium and potassium quantity in the transported fluid (Table 2) .
Methylprednisolone, injected subcutaneously in a single dose of 3 0 mg/100 g b.w., 30 minutes before the intraperitoneal injection of either colchicine or vinblastine, prevented the inhibitory effect of colchicine and vinblastine on fluid transport. The amount of fluid transported did not differ significantly from that transported by segments of rats injected with 0-15 M NaCl or methylprednisolone alone (Table 1) . Rats were injected intraperitoneally with either 015 M NaCl 05 ml/ lOOg body wt, colchicine 05 mg/100 g body wt, vinblastine 1 0 mg/100 g body wt, or subcutaneously methylprednisolone 3 0 mg/100 g body wt. In some experiments methylprednisolone was injected 30 minutes before the colchicine or vinblastine. Infusions of jejunal segments with buffer were performed as described in the Methods section. Values are means ± SE. tavs.bP < 00l;avs.cP < 0i)l;bvs.dP < 00l;cvs.e P < 0-01. Table 1 .
Infusion of jejunal segments with buffer and measurement of Na and K content in transported fluid were performed as described in the Methods section. Values are means + SE. tavs.bP < 00l;avs.c P < 00l;bvs.esP < 0-0l;cvs.fP < 0-01. AvsBP < 00l;Avs.CNS;Bvs.EP < 00l;Cvs.F P < 005.
(Gtmol = iu equiv.)
Intestinal Mg-ATPase and Na-K-ATPase activities were measured four hours after the intraperitoneal injection of either 0 15 M NaCI, colchicine 0 5 mg/100 g b.w. or vinblastine 1 0 mg/100 g b.w. in rats treated and not treated with methylprednisolone. The results obtained in these series of experiments are summarised in Table 3 . Mg-ATPase activity was similar in the groups injected with 0 15 M NaCI, colchicine, methylprednisolone, and methylprednisolone plus colchicine. Mg-ATPase activity in the vinblastine injected group was lower than that in the other groups. Intestinal Na-K-ATPase activity was markedly decreased in rats injected with either colchicine or vinblastine as compared to rats injected with 015 M NaCl. Methylprednisolone stimulated significantly Na-K-ATPase activity as compared to that observed in 0 15 M NaCl treated rats. The same magnitude of inhibition in Na-K-ATPase activity 761 was induced by colchicine and vinblastine both in the 0-15 M NaCl and methylprednisolone treated rats. Pretreatment with methylprednisolone prevented the decrease in intestinal Na-K-ATPase activity observed following colchicine or vinblastine. Addition of 30 and 60 ,ug colchicine or of 60 and 120 p,g vinblastine to 5 0 mg of the assay medium did not interfere with the detection of both enzymes' activities. The degree ofinhibition in intestinal Na-K-ATPase activity was similar to the decrease observed in fluid transport following colchicine and vinblastine. The reversal effect of methylprednisolone on enzyme activity and fluid transport was also of the same magnitude (Fig. 1) . In order to check whether the effects of colchicine on fluid transport and enzyme activities can be separated, both were measured one and two hours after the administration of the drug.
As can be seen in Fig. 2 , one and two hours after its administration, colchicine decreased fluid transport and inhibited Na-K-ATPase significantly as compared to rats injected with 0 15 M NaCl (p < 0 01). The degree of inhibition in the enzyme activity was similar to the decrease in fluid transport at both time intervals. Histologically, it was impossible to distinguish between jejunums from rats treated with colchicine or with methylprednisolone and colchicine. In both groups the jejunal surface absorptive cells were tall columnar, had basally oriented nuclei and a normal appearing brush border. In the crypts of both groups mitotic arrest in metaphase was observed. In the groups injected with vinblastine or methylprednisolone plus vinblastine besides mitotic arrest in metaphase, other changes were observed: vacuolisation, focal disarray of nuclei, accumulation of nuclear debris, and disappearance of the brush bor- der were noted among the superficial absorptive intestinal segment. This system was used in order to cells.
study the effects of colchicine and vinblastine on water transport by the rat's jejunum. It is imposDiscussion sible to differentiate in this system whether the inhibition of fluid transport is the result of decreased The in vitro intestinal infusion system (Parsons and absorption or increased secretion. However, the Volman-Mitchell, 1974) allows easy collection of results obtained illustrate that both colchicine and transported fluid at the serosal surface of the infused vinblastine in the doses used decreased significantly the transport of fluid by the rat's jejunum.
Pretreatment with methylprednisolone prevented the inhibitory effect of colchicine on water transport. This observation might be explained on the basis of the data showing that methylprednisolone increases sodium and water absorption, potassium secretion, and Na+-K+-ATPase activity in the jejunum of rats (Charney et al., 1975) . Even though adenylate cyclase is the mediator in choleragen-induced intestinal secretion, it has also been shown that methylprednisolone may prevent and reverse the secretory effects of choleragen by increasing mucosal Na-KATPase activity (Charney and Donowitz, 1976) .
In the present study we confirmed again that methylprednisolone increases intestinal Na-KATPase activity. Moreover, methylprednisolone was shown to prevent the decrease in the enzyme activity observed following the administration of colchicine and vinblastine.
Our results thus suggest, that inhibition of Na-KATPase activity by colchicine and vinblastine, in addition to their effects on intestinal morphology and other enzyme activities, might contribute to the inhibition of water transport from the rat intestine induced by them.
Colchicine, in the dose injected, was already effective one hour after its administration. At all time intervals studied, it was impossible to differentiate between colchicine's effect on water transport and Na+-K+-ATPase activity. This further supports the contention that its inhibition of water transport is related to the inhibition of Na+-K+-ATPase activity.
Colchicine in the dose range used does not interfere in protein synthesis (Rossignol et al., 1972) and thus the lower Na-K-ATPase activity is not due to inhibition of the enzyme synthesis. Colchicine has been shown to effect release of various hormones (Lacy et al., 1968; Williams and Wolff, 1970; Douglas and Sorimachi, 1972) into the circulation, it could thus affect the transport of Na-K-ATPase from its storage site. Another possibility to be considered is that colchicine might interfere with the final step of enzyme release if it is transported to its location on the lateral membrane fraction of the cell (Quigley and Gotterer, 1969) (Stadler and Franke, 1974) and by this can prevent the fusion of the enzyme carrying plasmalemmal vesicles with the plasma membrane and thus to reduce the amount of available enzymes.
Methylprednisolone prevents less effectively the inhibition of Na+-K+-ATPase activity observed after the administration of vinblastine. This could be partially explained on the basis of the histological changes observed in jejunum of rats treated with vinblastine or with methylprednisolone and vinblastine. In both groups significant changes were found in the superficial absorptive cells in addition to the mitotic arrest in metaphase observed in the colchicine treated rats.
This study demonstrated decreased absorptive capacity induced by colchicine and vinblastine without any evidence of increased secretion. The doses of coichicine, vinblastine, and methylprednisolone used in this study are also huge in comparison to the doses used for therapeutic purposes in humans. However, the fact that methylprednisolone was shown to prevent the effect of colchicine both on fluid transport and on Na-K-ATPase activity might be used to prevent diarrhoea in patients receiving colchicine or vinblastine for therapeutic purposes. 
